Answer
When Cinqaero (reslizumab) is administered, the name and batch number of the administered product should be clearly recorded to improve traceability.
Sources for this answer
- Cinqaero (reslizumab) 10 mg/mL concentrate for solution for infusionTeva Pharmaceuticals Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked